Literature DB >> 2254225

Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci.

R P Mouton1, J Hermans, A M Simoons-Smit, J A Hoogkamp-Korstanje, J E Degener, B van Klingeren.   

Abstract

The correlation between antibiotic consumption, expressed in defined daily doses (DDD), and antibiotic resistance rates was studied, using 976 isolates of coagulase negative staphylococci (CNS) from human pathological material. Data from four hospitals, including 14 participating departments, were analysed for this purpose. Susceptibility tests were performed according to Dutch national standards, except for methicillin, which for the majority of isolates was tested according to adapted NCCLS standards. Resistance to methicillin was most frequent in Staphylococcus epidermidis (29%) and S. haemolyticus (16%). Among the departments, thoracic surgery (29-47%), surgical intensive care (68%) and neonatology (32%) scored highest. Significant correlations were found between percentages of methicillin resistance in CNS and consumption (DDD/month/bed) of (flu)cloxacillin (P0.008), of cephalosporins (P0.01) and of gentamicin (P0.005). (Flu)cloxacillin was used mainly prophylactically, cephalosporins and gentamicin therapeutically. Results were similar for S. epidermidis (n = 639) alone. There was no significant correlation between consumption and resistance to trimethoprim, erythromycin (P0.08) or gentamicin (P0.09). Analysis of data from individual patients showed significant differences in proportions of methicillin resistance rates in CNS, between use and non-use of penicillinase resistant beta-lactams or gentamicin. It is concluded that clinical use of both (flu)cloxacillin and cephalosporins selects for methicillin resistant CNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254225     DOI: 10.1093/jac/26.4.573

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Consumption of antibiotics in Sweden, 1975 to 1992: pharmacoeconomic and clinical aspects.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

Review 2.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

3.  Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period.

Authors:  O Lyytikäinen; M Vaara; E Järviluoma; K Rosenqvist; L Tiittanen; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

4.  Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark.

Authors:  F M Aarestrup; A M Seyfarth; H D Emborg; K Pedersen; R S Hendriksen; F Bager
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 5.  Combination therapy for treatment of infections with gram-negative bacteria.

Authors:  Pranita D Tamma; Sara E Cosgrove; Lisa L Maragakis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  A European study on the relationship between antimicrobial use and antimicrobial resistance.

Authors:  Stef L A M Bronzwaer; Otto Cars; Udo Buchholz; Sigvard Mölstad; Wim Goettsch; Irene K Veldhuijzen; Jacob L Kool; Marc J W Sprenger; John E Degener
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

7.  Generalized additive model demonstrates fluoroquinolone use/resistance relationships for Staphylococcus aureus.

Authors:  Pierre Berger; Laurence Pascal; Catherine Sartor; Jean Delorme; Philippe Monge; Christine Penot Ragon; Martine Charbit; Roland Sambuc; Michel Drancourt
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

8.  Nosocomial infection by Staphylococcus haemolyticus and typing methods for epidemiological study.

Authors:  J E Degener; M E Heck; W J van Leeuwen; C Heemskerk; A Crielaard; P Joosten; P Caesar
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

9.  Increasing Resistance of Coagulase-Negative Staphylococci in Total Hip Arthroplasty Infections: 278 THA-Revisions due to Infection Reported to the Norwegian Arthroplasty Register from 1993 to 2007.

Authors:  Olav Lutro; Håkon Langvatn; Håvard Dale; Johannes Cornelis Schrama; Geir Hallan; Birgitte Espehaug; Haakon Sjursen; Lars B Engesæter
Journal:  Adv Orthop       Date:  2014-10-09

10.  Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues.

Authors:  Qi Chen; Peng Cheng; Chengbang Ma; Xinping Xi; Lei Wang; Mei Zhou; Huimin Bian; Tianbao Chen
Journal:  Toxins (Basel)       Date:  2018-10-13       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.